Roblin, D., G. Yosipovitch, B. Boyce, J. Robinson, J. Sandy, V. Mainero, R. Wickramasinghe, U. Anand, and P. Anand. “Topical TrkA Kinase Inhibitor CT327 Is an Effective, Novel Therapy for the Treatment of Pruritus Due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients With Psoriasis”. Acta Dermato-Venereologica, vol. 95, no. 5, Feb. 2015, pp. 542-8, doi:10.2340/00015555-2047.